AstraZeneca PLC
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Other Rare Disease medicines — US product sales by Year
Other Rare Disease medicines — US product sales ($M) ($M)
AstraZeneca Other Rare Disease medicines — US product sales: $113M in FY2025.
Where the FY2025 figure comes from
“|| Other Rare Disease | 231 | 11 | 10 | 113 | 14 | 40 | 16 | 18 | 67 | 1 | (2) | 11 | 23 | 23”
Source: Form 6-K FY2025Q4 Earnings Release ↗
Reported in Form 6-K / 20-F Product Sales Table.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other Rare Disease medicines — US product sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 113 | – | Form 6-K FY2025Q4 Earnings Release ↗ |
Breakdown
What makes up other Rare Disease medicines — US product sales
Cite this data
StockData. (2026). AstraZeneca Other Rare Disease medicines — US product sales ($M), annual FY2025–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-other-rare-us
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.